Test Price
160 AED✅ Home Collection Available
CA 125 Ovarian Cancer Marker Test in UAE | 160 AED | DNA Labs UAE
Executive Summary & Core Metrics
- Guaranteed Accuracy: 99.9% diagnostic sensitivity through ISO 9001:2015 certified processing.
- Concierge Logistics: Hospital-grade home blood collection via certified cold-chain, and VIP mobile phlebotomy.
- Clinical Guidance: Post-test telephonic consultation to interpret your results with a specialist.
- Insurance: Direct billing verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The CA 125 test quantifies cancer antigen 125, a key biomarker for ovarian cancer monitoring and risk stratification. This quantitative test employs Chemiluminescent Microparticle Immunoassay (CMIA) technology, ensuring high precision and reproducibility for ongoing patient management. It is commonly used to monitor treatment response in patients diagnosed with ovarian cancer and to detect recurrence.
| Feature | Our Test | Closest Alternative |
|---|---|---|
| Precision | CV < 3% across the analytical range | CV 5–7% (Central laboratory) |
| Methodology | CMIA (Chemiluminescent Microparticle Immunoassay) | Older ELISA or ECLIA |
| Report Speed | Daily report (24 hours) | 48–72 hours |
Physician Insight & Safety Protocols
“As a specialist in diagnostic radiology, I emphasize that an elevated CA 125 level is not synonymous with a cancer diagnosis. It must be interpreted alongside clinical examination and imaging findings. My role is to guide you through this diagnostic journey, ensuring accurate understanding and appropriate next steps.”
— Mr. Prabhakar Reddy Kalathoor, Specialist Diagnostic Radiology, DHA License: 61713011
Medication Safety Advisory
Do not discontinue prescribed medications without consulting your physician. The CA 125 test is a monitoring tool and should not replace your current treatment plan without professional guidance.
Exclusion Criteria & Emergency Red Flags
- Acute urinary retention or unexplained sudden abdominal pain.
- Heavy vaginal bleeding unrelated to menstruation.
- Fever (>38.5°C) with acute pelvic pain.
- Pregnancy – this test is not recommended as a routine screening tool during pregnancy.
- Minors (under 18) without a legal guardian.
Patient FAQ & Clinical Guidance
1. When should I get a CA 125 test?
You should consider this test if you have a family history of ovarian or breast cancer, or if you present with persistent bloating, pelvic pain, or urinary urgency. Your physician may also order it to monitor treatment response in confirmed ovarian cancer cases. Please consult your doctor for a comprehensive risk assessment.
2. Can non-cancerous conditions cause elevated CA 125?
Yes, CA 125 can be elevated due to benign conditions such as endometriosis, uterine fibroids, pelvic inflammatory disease, or even menstruation. Your physician will interpret the result in the full context of your clinical history and imaging studies to ensure an accurate diagnosis.
3. What is the difference between CA 125 and an ultrasound?
While ultrasound visualizes structural abnormalities of the ovaries, CA 125 detects a glycoprotein shed by tumor cells. These are complementary tools used together to enhance diagnostic accuracy and risk stratification. Neither test is definitive alone, but combined they provide powerful clinical insights.
UAE Regulatory & Data Privacy Adherence
This test operates in full compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical safety and patient consent protocols adhere strictly to Federal Decree-Law No. 4 of 2016 on Medical Liability. All patient data is encrypted and processed exclusively within the UAE. The facility is fully licensed (DHA License: 1143) and accredited under ISO 9001:2015, ensuring the highest standards of quality and security.
Clinical & Logistical Metadata
| Test Name | CA 125 Ovarian Cancer Marker Test |
| Price (AED) | 160 |
| Turnaround Time | 24 Hours |
| Sample Type / Matrix | Serum or Plasma (VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection available daily from 8 AM to 11 PM) |
| Methodology Used | Chemiluminescent Microparticle Immunoassay (CMIA) |
| ICD-10-CM Code | Z12.73, C56.9 |
| LOINC Code | 10334-9 |
| DHA Facility License & Laboratory Address | DHA License: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians